Bradley Foster & Sargent Inc/Ct / LLY
Bradley Foster & Sargent Inc/Ct’s Eli Lilly & Co Position
Does Bradley Foster & Sargent Inc/Ct own Eli Lilly & Co (LLY)? Yes — 27.1K shares worth $25M (+0.39% of its 13F portfolio) as of Q1 2026, up from 26.2K shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
27.1K
% of Portfolio
+0.39%
Quarters Held
28
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 27.1K | $25M | +0.39% |
| Q4 2025 | 26.2K | $28M | +0.41% |
| Q3 2025 | 25.7K | $20M | +0.29% |
| Q2 2025 | 25.1K | $20M | +0.31% |
| Q1 2025 | 24.3K | $20M | +0.34% |
| Q4 2024 | 19.7K | $15M | +0.26% |
| Q3 2024 | 20.6K | $18M | +0.31% |
| Q2 2024 | 20.2K | $18M | +0.33% |
| Q1 2024 | 19.6K | $15M | +0.28% |
| Q4 2023 | 18.9K | $11M | +0.21% |
| Q3 2023 | 21.3K | $10M | +0.21% |
| Q2 2023 | 21.3K | $10M | +0.21% |
| Q1 2023 | 20.9K | $7M | +0.17% |
| Q4 2022 | 21.0K | $8M | +0.19% |
| Q3 2022 | 20.8K | $7M | +0.19% |
| Q2 2022 | 20.8K | $7M | +0.17% |
| Q1 2022 | 20.4K | $6M | +0.12% |
| Q3 2021 | 15.9K | $4M | +0.09% |
| Q2 2021 | 20.3K | $5M | +0.11% |
| Q1 2021 | 20.7K | $4M | +0.10% |
| Q4 2020 | 32.8K | $6M | +0.15% |
| Q3 2020 | 32.9K | $5M | +0.14% |
| Q1 2020 | 33.6K | $5M | +0.19% |
| Q4 2019 | 32.8K | $4M | +0.13% |
| Q3 2019 | 32.7K | $4M | +0.12% |
| Q2 2019 | 32.9K | $4M | +0.12% |
| Q1 2019 | 33.1K | $4M | +0.15% |
| Q4 2018 | 33.0K | $4M | +0.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bradley Foster & Sargent Inc/Ct’s full portfolio or all institutional holders of LLY.